Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ForeignMan
    Member
    • Jun 2010
    • 20

    #1

    Handling duplicates and other biases in Haloplex enriched targeted sequencing data

    Hello everyone,

    we're starting to work with deep sequencing data of target regions that were enriched by Agilent's Haloplex kit (Illumina MiSeq, paired-end, often >500x mean seq. depth).
    How would you handle duplicate reads after alignment? The initial DNA fragmentation by restriction enzymes seems to make it impossible to remove duplicates (from PCR mainly) just like for random fragmentation. If you kept all the duplicates, does the amplification bias or other biases like strand bias hamper mutation detection significantly?

    Would be great if someone had some experience he'd like to share and discuss here or knew some literature that presents some work with Haloplex sequencing data (which seems to be quite rare).

    Thanks in advance,
    Chris
  • fzhang03
    Junior Member
    • Oct 2008
    • 2

    #2
    In our Haloplex library sequencing results, we saw 200x coverage for all probed regions, but, after removing duplicated reads, it is 6x coverage. We don't know how to handle this issue yet.

    Comment

    • yl01
      Member
      • Aug 2012
      • 25

      #3
      The advice we got from Agilent support people is that for Haloplex data it is important not to remove PCR duplicates. Haloplex data sets are expected to produce a lot of reads with exact same start / end genomic coordinates (corresponding to the restriction enzyme sites), which will be seen as duplicates, but should not be removed from the analysis.

      Comment

      • fzhang03
        Junior Member
        • Oct 2008
        • 2

        #4
        Thanks! that's helpful.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...